BiotechTube
Home/RedHill Biopharma/Dror Ben-Asher
DB

Dror Ben-Asher

Chief Executive Officer

RedHill Biopharma

Therapeutic Areas

GastroenterologyInfectious DiseaseOncology

RedHill Biopharma Pipeline

DrugIndicationPhase
Opaganib (ABC294640)COVID-19 (Severe Hospitalized)Phase 2/3
OpaganibProstate CancerPhase 2
RHB-107 (Upamostat)COVID-19 (Non-Hospitalized)Phase 3
RHB-107Cancer (Solid Tumors)Phase 1/2
RHB-204Pulmonary Nontuberculous Mycobacteria (NTM) DiseasePhase 3

Leadership Team at RedHill Biopharma

GR
Gilead Raday
Chief Operating Officer and Head of R&D
MB
Micha Ben Chorin
Chief Financial Officer
RF
Reza Fathi
Senior VP, R&D
View full RedHill Biopharma profile